Stock Events

Stock Events

XOMA Royalty 

$26.48
66
-$0.27-1.01% Thursday 20:00

Statistics

Day High
27.3
Day Low
26.41
52W High
30
52W Low
24.96
Volume
4,301
Avg. Volume
908
Mkt Cap
327.9M
P/E Ratio
26.06
Dividend Yield
8.14%
Dividend
2.16

Upcoming

15
APR
Dividend Payment
 
3
JUL
Dividend Ex
Estimated
 
15
JUL
Dividend Payment
Estimated
 
5
OCT
Dividend Ex
Estimated
 
15
OCT
Dividend Payment
Estimated
 

Dividends

8.14%Dividend Yield
Apr 26
$0.54
Jan 26
$0.54
Oct 25
$0.54
Jul 25
$0.54
Apr 25
$0.54
10Y Growth
N/A
5Y Growth
3.71%
3Y Growth
N/A
1Y Growth
N/A

Earnings

30AprExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-1.59
-0.78
0.03
0.84
Expected EPS
0.1575
Actual EPS
N/A

Financials

-48.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
56.97MRevenue
-27.64MNet Income

Analyst Ratings

$74.33Average Price Target
The highest estimate is 97.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XOMAP. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals competes in the biotechnology industry focusing on developing and commercializing medicines for serious medical conditions, similar to XOMA's focus on antibody-based therapeutics.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biopharmaceutical company that discovers, develops, manufactures, and delivers innovative human therapeutics, competing directly with XOMA in the biotech sector.
Biogen
BIIB
Mkt Cap22.63B
Biogen competes with XOMA in the biotechnology field, focusing on developing therapies for neurological and neurodegenerative diseases.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas similar to XOMA, making them direct competitors.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is involved in creating new possibilities in medicine to cure diseases and improve people's lives, competing with XOMA in the biotech innovation space.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, competing with XOMA in the development of novel therapeutics.
Incyte
INCY
Mkt Cap18.35B
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics, making it a competitor in the biopharmaceutical space alongside XOMA.
Nektar Therapeutics
NKTR
Mkt Cap1.23B
Nektar Therapeutics is involved in developing new treatment options in various therapeutic areas, competing with XOMA in the innovation of biologic drugs.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical focuses on developing and commercializing innovative biopharmaceuticals for rare diseases, competing with XOMA in targeting niche markets with specialized treatments.

About

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Show more...
CEO
Mr. Owen P. Hughes Jr.
Employees
13
Country
BM
ISIN
US98419J3059

Listings

F
DE
X0M1.F
F
DE
X0M.F
BOATS
BOATS
XOMAO.BOATS
LSE
GB
0M26.LSE

0 Comments

Share your thoughts

FAQ

What is XOMA Royalty stock price today?▼
The current price of XOMAP is $26.48 USD — it has decreased by -1.01% in the past 24 hours. Watch XOMA Royalty stock price performance more closely on the chart.
What is XOMA Royalty stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange XOMA Royalty stocks are traded under the ticker XOMAP.
Is XOMA Royalty stock price growing?▼
XOMAP stock has risen by +2.83% compared to the previous week, the month change is a +2.76% rise, over the last year XOMA Royalty has showed a +2.87% increase.
What is XOMA Royalty market cap?▼
Today XOMA Royalty has the market capitalization of 327.9M
When is the next XOMA Royalty earnings date?▼
XOMA Royalty is going to release the next earnings report on April 30, 2026.
What were XOMA Royalty earnings last quarter?▼
XOMAP earnings for the last quarter are 0.7 USD per share, whereas the estimation was -0.04 USD resulting in a +1,850% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is XOMA Royalty revenue for the last year?▼
XOMA Royalty revenue for the last year amounts to 56.97M USD.
What is XOMA Royalty net income for the last year?▼
XOMAP net income for the last year is -27.64M USD.
Does XOMA Royalty pay dividends?▼
Yes, XOMAP dividends are paid quarterly. The last dividend per share was 0.54 USD. As of today, Dividend Yield (FWD)% is 8.14%.
How many employees does XOMA Royalty have?▼
As of April 03, 2026, the company has 13 employees.
In which sector is XOMA Royalty located?▼
XOMA Royalty operates in the Health Care sector.
When did XOMA Royalty complete a stock split?▼
XOMA Royalty has not had any recent stock splits.
Where is XOMA Royalty headquartered?▼
XOMA Royalty is headquartered in EmeryVille, BM.